REVI
Device
BLUEWIND MEDICAL
Total Payments
$2.1M
Transactions
1,878
Doctors
576
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $2.1M | 1,878 | 576 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.6M | 568 | 77.1% |
| Consulting Fee | $354,396 | 71 | 16.9% |
| Travel and Lodging | $79,557 | 303 | 3.8% |
| Food and Beverage | $46,805 | 936 | 2.2% |
Payments by Type
Research
$1.6M
568 transactions
General
$480,758
1,310 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| RESTORE: AN RCT TO EVAULATE THE EFFICACY OF THE REVI SYSTEM | BLUEWIND MEDICAL | $1.1M | 0 |
| BLUEWIND RENOVA ISTIM SYSTEM FOR THE TREATMENT OF OAB (OASIS) | BLUEWIND MEDICAL | $505,495 | 0 |
Ad
Manufacturing Companies
- BLUEWIND MEDICAL $2.1M
Product Information
- Type Device
- Total Payments $2.1M
- Total Doctors 576
- Transactions 1,878
About REVI
REVI is a device associated with $2.1M in payments to 576 healthcare providers, recorded across 1,878 transactions in the CMS Open Payments database. The primary manufacturer is BLUEWIND MEDICAL.
Payment data is available from 2024 to 2024. In 2024, $2.1M was paid across 1,878 transactions to 576 doctors.
The most common payment nature for REVI is "Unspecified" ($1.6M, 77.1% of total).
REVI is associated with 2 research studies, including "RESTORE: AN RCT TO EVAULATE THE EFFICACY OF THE REVI SYSTEM" ($1.1M).